CTAA 28A32, the antigen recognized by MCA 28A32
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 28, 1996
Issued Date -
N/A
app pub date -
Apr 1, 1993
filing date -
Jan 31, 1984
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention comprises the epitope recognized by the human monoclonal antibody 28A32, the human tumor antigen containing this epitope, which we have identified, isolated and characterized, and human MCA 28A32. The invention also relates to the use of antibodies to the antigen containing this epitope for diagnosis and monitoring of treatment of cancer and to the use of this antigen in the preparation of vaccines to elicit an immune response similar to that obtained against tumor cells containing this epitope.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully